Immunovant, Inc. Annual Depreciation in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Immunovant, Inc. quarterly/annual Depreciation history and growth rate from 2018 to 2023.
  • Immunovant, Inc. Depreciation for the quarter ending June 30, 2024 was $80K, a 50.9% increase year-over-year.
  • Immunovant, Inc. annual Depreciation for 2023 was $231K, a 19.7% increase from 2022.
  • Immunovant, Inc. annual Depreciation for 2022 was $193K, a 53.2% increase from 2021.
  • Immunovant, Inc. annual Depreciation for 2021 was $126K, a 93.8% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $231K +$38K +19.7% Apr 1, 2023 Mar 31, 2024 10-K 2024-05-29
2022 $193K +$67K +53.2% Apr 1, 2022 Mar 31, 2023 10-K 2024-05-29
2021 $126K +$61K +93.8% Apr 1, 2021 Mar 31, 2022 10-K 2023-05-22
2020 $65K +$44K +210% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-08
2019 $21K +$11K +110% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-01
2018 $10K Apr 1, 2018 Mar 31, 2019 10-K 2020-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.